Innate Immune Responses to SARS-CoV-2 Infections

The innate immune system constitutes the first line of defence against SARS-CoV-2, relying on specialised sensors to detect viral components and trigger rapid responses. Pattern recognition receptors such as Toll-like receptors (TLRs) and cytosolic sensors engage viral RNA and structural proteins, leading to activation of signalling pathways including NF-κB and interferon regulatory factors. These pathways orchestrate the production of type I and type III interferons, pro-inflammatory cytokines (for example interleukin-6, tumour necrosis factor) and chemokines that recruit monocytes, neutrophils and natural killer cells to the site of infection. In parallel, the NLRP3 inflammasome assembles in macrophages and monocytes, driving maturation of interleukin-1β and amplifying inflammation. While early interferon responses can limit viral replication, excessive or dysregulated activation of inflammasomes and NF-κB may precipitate a hyperinflammatory state or “cytokine storm”, contributing to lung injury and systemic complications. Understanding these pathways has underpinned the development of immunomodulatory therapies and guided timing for antiviral and anti-inflammatory agents in clinical management of COVID-19.

Research from Nature Portfolio

Recent studies have delineated how distinct viral proteins differentially engage innate sensors to shape monocyte and macrophage responses. Work on monocytes exposed to the spike subunit versus nucleoprotein has revealed that spike drives differentiation into transitional and non-classical subsets via NF-κB, whereas inflammasome components NLRP3 and NLRC4 selectively modulate co-stimulatory marker expression. Functional consequences include enhanced Th1 and Th17 skewing by spike‐trained monocytes and impaired CD8+ T‐cell degranulation after nucleoprotein exposure, suggesting protein‐specific immunopathology and novel therapeutic targets. In parallel, foundational research into early type I interferon signatures has underscored their pivotal role in limiting viral spread and tempering downstream inflammation, with impaired interferon responses correlating with severe disease.

Innate Immune Responses to SARS-CoV-2 Infections publication trend

The graph below shows the total number of articles in innate immune responses to sars-cov-2 infections across all publications each year (not limited to Nature Index journals).

Technical terms

Pattern recognition receptor (PRR): A host sensor that recognises conserved microbial molecules to initiate innate immunity.

Inflammasome: A multiprotein complex that activates inflammatory caspases and matures interleukin-1β.

NF-κB: A transcription factor central to expression of pro-inflammatory cytokines and chemokines.

Type I interferon: A family of cytokines (primarily IFN-α/β) that induce antiviral gene programmes.

Cytokine storm: An excessive release of inflammatory mediators leading to tissue damage and organ dysfunction.

References

1. NFκB and NLRP3/NLRC4 inflammasomes regulate differentiation, activation and functional properties of monocytes in response to distinct SARS-CoV-2 proteins. Nature Communications (2024).
2. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway. eLife (2021).
3. SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages. Heliyon (2021).
4. SARS-CoV-2-associated ssRNAs activate inflammation and immunity via TLR7/8. JCI Insight (2021).